Tenet Healthcare THC
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Tenet Healthcare (THC) Business Model and Operations Summary
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of December 2023) and over 450 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Key Insights
Tenet Healthcare (THC) Core Market Data and Business Metrics
Latest Closing Price
$137.18Market Cap
$13.02 BillionPrice-Earnings Ratio
4.20Total Outstanding Shares
97.68 Million SharesTotal Employees
106,500Dividend
No dividendIPO Date
March 31, 1976SIC Description
Pharmaceutical PreparationsPrimary Exchange
New York Stock ExchangeHeadquarters
101 Glen Lennox Drive, Chapel Hill, NC, 27517
Historical Stock Splits
If you bought 4 shares of THC before October 11, 2012, you'd have 1 share today.
| Execution Date | Split Amount |
|---|---|
| October 11, 2012 | 1-for-4 (Reverse Split) |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 1,518,377 Shares | 2.55 | 3/14/2025 | 3,869,343 Shares |
| 1,956,629 Shares | 1.76 | 2/28/2025 | 3,437,394 Shares |
| 1,702,216 Shares | 2.01 | 2/14/2025 | 3,422,809 Shares |
| 997,042 Shares | 2.98 | 1/31/2025 | 2,966,869 Shares |
| 1,059,079 Shares | 3.35 | 1/15/2025 | 3,542,739 Shares |
| 1,642,336 Shares | 2.18 | 12/31/2024 | 3,579,515 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow | $1.79 Billion |
| Net Cash Flow From Operating Activities, Continuing | $2.05 Billion |
| Net Cash Flow From Investing Activities, Continuing | $3.43 Billion |
| Net Cash Flow From Financing Activities | $-3.69 Billion |
| Net Cash Flow From Operating Activities | $2.05 Billion |
| Net Cash Flow, Continuing | $1.79 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Diluted Earnings Per Share | $32.70 |
| Benefits Costs and Expenses | $15.42 Billion |
| Income/Loss Before Equity Method Investments | $4.99 Billion |
| Income Tax Expense/Benefit | $1.18 Billion |
| Operating Income/Loss | $5.96 Billion |
| Income/Loss From Continuing Operations Before Tax | $5.25 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $864 Million |
| Other Comprehensive Income/Loss | $1 Million |
| Comprehensive Income/Loss | $4.07 Billion |
| Comprehensive Income/Loss Attributable To Parent | $3.20 Billion |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Wages | $899 Million |
| Current Assets | $7.68 Billion |
| Other Non-current Assets | $16.82 Billion |
| Equity Attributable To Noncontrolling Interest | $1.65 Billion |
| Equity Attributable To Parent | $4.17 Billion |
| Noncurrent Assets | $21.25 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||